P. Van Rooy
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
-
- Antifungal resistance and susceptibility 4
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- G. Cauwenbergh (4 shared papers)J. Heykants (2 shared papers)R. Woestenborghs (2 shared papers)W. Meuldermans (1 shared paper)Karel Lavrijsen (1 shared paper)A. Van Peer (1 shared paper)J. Van Cutsem (1 shared paper)Vera Van de Velde (1 shared paper)
- Journals
- Diabetologia (2 papers)Journal of the American Academy of Dermatology (1 paper)Drugs (1 paper)American Journal of Reproductive Immunology (1 paper)The Prostate (1 paper)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
P. Van Rooy
18 papers receiving 818 citations
Peers
Comparison fields: 5 of 98
- Infectious Diseases 402
- Pharmaceutical Science 89
- Epidemiology 446
- Small Animals 92
- Pharmacology 90
Countries citing papers authored by P. Van Rooy
This map shows the geographic impact of P. Van Rooy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Van Rooy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Van Rooy more than expected).
Fields of papers citing papers by P. Van Rooy
This network shows the impact of papers produced by P. Van Rooy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Van Rooy. The network helps show where P. Van Rooy may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Van Rooy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 329 | |
| 2 | 1988 | 213 | |
| 3 | Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole. | 1996 | 97 |
| 4 | 1996 | 80 | |
| 5 | 1990 | 50 | |
| 6 | 1989 | 31 | |
| 7 | A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group. | 1992 | 20 |
| 8 | 2006 | 16 | |
| 9 | 1993 | 8 | |
| 10 | 1992 | 7 | |
| 11 | 1991 | 5 | |
| 12 | 1983 | 5 | |
| 13 | 1985 | 5 | |
| 14 | 1992 | 4 | |
| 15 | 1981 | 3 | |
| 16 | 1991 | 2 | |
| 17 | 1987 | 2 | |
| 18 | The safety and tolerability of single intravenous doses of lubeluzole (Prosynap) in healthy volunteers. | 1997 | 2 |
About P. Van Rooy
P. Van Rooy is a scholar working on Infectious Diseases, Pharmacology, Physiology, Surgery and Molecular Biology, having authored 18 papers that have together received 879 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (2 papers), Pain Mechanisms and Treatments (2 papers), Nail Diseases and Treatments (2 papers), Pancreatic function and diabetes (1 paper), Cancer Treatment and Pharmacology (1 paper) and Diabetes Management and Research (1 paper). The work is most often cited by research in Infectious Diseases (402 citations), Pharmaceutical Science (89 citations), Epidemiology (446 citations), Small Animals (92 citations) and Pharmacology (90 citations). P. Van Rooy has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include G. Cauwenbergh, J. Heykants, R. Woestenborghs, W. Meuldermans, Karel Lavrijsen, A. Van Peer, J. Van Cutsem, Vera Van de Velde, H. Degreef and J Heykants. Their work appears in journals such as Diabetologia, Journal of the American Academy of Dermatology, Drugs, American Journal of Reproductive Immunology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.